ALPS Advisors’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-66,403
Closed -$1.28M 1036
2024
Q3
$1.28M Buy
66,403
+110
+0.2% +$2.12K 0.01% 439
2024
Q2
$1.36M Buy
66,293
+6,369
+11% +$131K 0.01% 397
2024
Q1
$1.43M Buy
59,924
+11,798
+25% +$281K 0.01% 410
2023
Q4
$1.04M Sell
48,126
-3,110
-6% -$67.2K 0.01% 468
2023
Q3
$744K Buy
51,236
+651
+1% +$9.45K 0.01% 540
2023
Q2
$1.06M Buy
50,585
+5,496
+12% +$115K 0.01% 480
2023
Q1
$952K Sell
45,089
-317
-0.7% -$6.7K 0.01% 482
2022
Q4
$1.16M Buy
45,406
+14,554
+47% +$370K 0.01% 420
2022
Q3
$741K Sell
30,852
-2,504
-8% -$60.1K 0.01% 529
2022
Q2
$642K Sell
33,356
-23,180
-41% -$446K 0.01% 540
2022
Q1
$983K Sell
56,536
-1,643
-3% -$28.6K 0.01% 315
2021
Q4
$1.27M Sell
58,179
-1,414
-2% -$31K 0.01% 329
2021
Q3
$1.14M Sell
59,593
-3,948
-6% -$75.5K 0.01% 378
2021
Q2
$1.09M Buy
+63,541
New +$1.09M 0.01% 395
2018
Q4
Sell
-41,328
Closed -$334K 931
2018
Q3
$334K Buy
41,328
+5,477
+15% +$44.3K ﹤0.01% 888
2018
Q2
$252K Buy
35,851
+3,139
+10% +$22.1K ﹤0.01% 893
2018
Q1
$465K Buy
32,712
+5,686
+21% +$80.8K ﹤0.01% 633
2017
Q4
$237K Buy
27,026
+5,143
+24% +$45.1K ﹤0.01% 782
2017
Q3
$256K Buy
21,883
+2,030
+10% +$23.7K ﹤0.01% 741
2017
Q2
$277K Buy
+19,853
New +$277K ﹤0.01% 731
2016
Q4
Sell
-22,669
Closed -$344K 730
2016
Q3
$344K Sell
22,669
-2,310
-9% -$35.1K ﹤0.01% 633
2016
Q2
$246K Buy
+24,979
New +$246K ﹤0.01% 591